Relief Therapeutics Holding AG (RLFTF)

[tcm55]

The Clinical Trial was for RLF-100 in the Frozen IV form. The CONTRACTS were written for the RLF-100 IV frozen formulation and all future formulations.. RELIEF owns that patent...

IMO, ANY attempts at changes or make upgrades to the Drug is OUTSIDE the Original Contracts. Negotiating Contracts regarding the Inhaled Formulation should be / are separate.

EMA and FDA applications are/will be for RLF-100 in that specific Frozen formulation. EUA s will be Granted for the Frozen Formulation. The Inhaled Formulation and any subsequent 'long shelf life' Formulations are Separate.

The USA market for COVID has dried up temporarily and NRX is using a Public opinion campaign to try for a larger part of the 'Rest of WORLD' Markets where COVID is in successive waves.
Truly disgusting of the "famous" dr JJ to PUBLICALLY delay the progress already achieved success with the IV Clinical Trial for a few questionable %...JMHFO...